HIV envelope-CD4 interaction not inhibited by synthetic octapeptides
- PMID: 2884513
- DOI: 10.1016/s0140-6736(87)90613-1
HIV envelope-CD4 interaction not inhibited by synthetic octapeptides
Similar articles
-
Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation.Science. 1989 Jun 2;244(4908):1075-8. doi: 10.1126/science.2543075. Science. 1989. PMID: 2543075
-
Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.Crit Rev Immunol. 1988;8(4):315-39. Crit Rev Immunol. 1988. PMID: 2850890 Review.
-
Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.Proc Natl Acad Sci U S A. 1987 Jul;84(13):4601-5. doi: 10.1073/pnas.84.13.4601. Proc Natl Acad Sci U S A. 1987. PMID: 3037522 Free PMC article.
-
Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization.Science. 1988 Feb 26;239(4843):1021-3. doi: 10.1126/science.2830667. Science. 1988. PMID: 2830667
-
The CD4 antigen: physiological ligand and HIV receptor.Cell. 1988 Mar 11;52(5):631-3. doi: 10.1016/0092-8674(88)90397-2. Cell. 1988. PMID: 2830988 Review. No abstract available.
Cited by
-
Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.J Neurovirol. 2006 Jun;12(3):178-89. doi: 10.1080/13550280600827344. J Neurovirol. 2006. PMID: 16877299 Clinical Trial.
-
Antiviral therapy in human immunodeficiency virus infection.Drugs. 1989 Sep;38(3):417-50. doi: 10.2165/00003495-198938030-00005. Drugs. 1989. PMID: 2680436 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials